Axios @axios
The U.S. has relied heavily on other countries' data when it comes to making booster decisions, particularly Israel's experience with Pfizer. But there's no Israel-like data for Moderna and Johnson & Johnson. https://t.co/rzMGnGwOoP — PolitiTweet.org